top of page

Central Nervous System EQA Programme

  • Arthropod-Borne Viruses

  • BK virus DNA

  • Borrelia burgdorferi spp. DNA

  • Central Nervous System I (Viral Meningitis and Encephalitis)

  • Central Nervous System II (Non-Viral Meningitis and Encephalitis)

  • Herpes simplex virus DNA

  • JC virus DNA

  • Enterovirus RNA

  • Measles and Mumps

  • Toxoplasma gondii DNA

  • Varicella-Zoster virus DNA

  • Parechovirus RNA

In recent years significant advances have been made in understanding CNS pathogenesis with the development of molecular technologies for the diagnosis and monitoring of disease, the introduction of effective treatment therapies and, in some cases, the development of vaccines (e.g. Japanese encephalitis & rabies). The range of QCMD EQA schemes within this area focus on pathogens known to play a significant clinical role in CNS infection. The general aim of this group of EQA schemes is to assess the laboratories’ ability in the detection and determination of the selected pathogen.


bottom of page